Summary
Drugs that interfere with the immune responsein vitro, such as azathioprine (AZ), have been used extensively since 1964 in clinical therapeutic trials of autoimmune diseases. However, few adequately controlled studies are available concerning the concurrent effect of AZ on the immune and clinical responses to treatment of rheumatoid arthritis (RA). Thirty patients suffering from classical seropositive RA received AZ (1.5 – 2.0 mg/kg/day) and placebo in a controlled clinical cross-over study for two 12-week periods. Other treatments were kept constant throughout the entire 6 months. In terms of the clinical responses of joint count and grip strength patients receiving AZ improved markedly, in contrast to the placebo group. After 2 months, joint scanning revealed no progress of the disease in patients undergoing AZ treatment. Corresponding with the remarkably beneficial clinical effect of AZ, a significant drop in immunoglobulins was observed. However, since AZ failed to suppressin vivo specific antibody synthesis in RA, the question remains as to whether this drug actually does interfere with the autoimmunogenesis of the disease.
Similar content being viewed by others
References
Butler, W.T., Rossen, R.D.: Effects of corticosteroids on immunity in man. J. clin. Invest.52 2629–2640 (1973)
Cridland, M.D.: Antineoplastic and immunosuppressive drugs. III. Adverse effects and therapeutic problems. Drugs3 352–365 (1972)
Currey, H.L.F., Harris, J., Mason, R.M., Woodland, J.M., Beveridge, T., Roberts, C.J., Vere, D.W., Dixon, A.St.J., Davies, J., Owen-Smith, B.: Comparison of azathioprine, cyclophosphamide, and gold in treatment of rheumatoid arthritis. Brit. med. J.1974 III 763–766
Ganner, E., Osment, J., Dittrich, P., Huber, H.: Chromosomes in patients treated with azathioprine. Hum. Genet.18 231–236 (1973)
Goebel, K.M., Gassel, W.D., Goebel, F.D.: Evaluation of azathioprine in autoimmune thrombocytopenia and lupus erythematodes. Scand. J. Haemat.10 28–34 (1973)
Goebel, K.M., Goebel, F.D., Gassel, W.D., Neitzert, A., Mueller, K.: Immune response in patients with autoimmune thrombocytopenia and autoimmune haemolytic anaemia receiving azathioprine. Klin. Wschr.52 916–920 (1974)
Harris, J., Jessop, J.D., Saintonge, D.M.: Further experience with azathioprine in rheumatoid arthritis. Brit. med. J.1971 IV 463–464
Hitchings, G.H., Elion, G.B.: Some aspects of immunosuppression. Ann. N. Y. Acad. Sci.129 799–803 (1966)
Jones, J.M., Martinez, A.J., Joshi, V.V., McWilliams, N.: Systemic lupus erythematosus. Clinical neuropathologic correlation. Arch. Path.99 152–157 (1975)
Kripke, M.L., Borsos, T.: Immunsuppression and carcinogenesis. Israel J. med. Sci.10 888–903 (1974)
Lansbury, J.: Methods for evaluating rheumatoid arthritis. In: Arthritis & allied conditions (ed. J.L. Hollander), pp. 781–845. Philadelphia: Lea & Febinger 1966
Levy, J., Barnett, E.V., Mac Donals, N.S., Klinenberg, J.R., Pearson, C.M.: The effects of azathioprine on gammaglobulin synthesis in man. J. clin. Invest.51 2233–2238 (1972)
Mason, M., Currey, H.L.F., Barnes, C.G., Dunne, J.F., Zazleman, B.L., Strickland, I.D.: Azathioprine in rheumatoid arthritis. Brit. med. J.1969 I 420–422
Moore, G., Harley, J.P., Otero, R.: Immunosuppressive activity of azathioprine in experimental infection of the mouse with trichinella spiralis. Experientia (Basel)30 952–953 (1974)
Rampon, S., Bussiere, J.L., Prin, Ph., Sauvezie, P., Leroy, V., Missioux, D., Doly, J., Suss, P., Jourde, H., Lapalus, F.: A propos de 250 observations de scintigraphie osseuse par le pyrophsphate d'etain marque au technetium 99 m. Rev. Rhum.41 745–751 (1974)
Ricken, D., Marsteller, H.J., Baack, G.: Immunsuppressive Behandlung der primär chronischen Polyarthritis und des Lupus erythematodes disseminatus. Med. Welt22 1501–1506 (1971)
Ropes, M.W., Benett, G.A., Cobb, S.: Revision of diagnostic criteria for rheumatoid arthritis. Bull. rheum. Dis.9 175–176 (1958)
Savage, O.: Measurements in rheumatoid arthritis. Proc. roy. Soc. Med.59 (Suppl. 85), (1966)
Scheiffarth, F., Warnatz, H.: Medikamentöse Immunsuppression der primär-chronischen Polyarthritis. In: Medikamentöse Immunsuppression (eds. D. Ricken, K. Schumacher), pp. 93–104. Stuttgart: Thieme 1971
Schumacher, H.R.: Synovial membrane and fluid morphologic alterations in early rheumatoid arthritis: Microvascular injury and virus-like particles. Ann. N. Y. Acad. Sci.256 39–65 (1975)
Stiller, C.R., Russel, A.S., Dossetor, J.B.: Autoimmunity: Present concepts. Ann. intern. Med.82 405–410 (1975)
Swanson, M.A., Schwartz, R.S.: Immunosuppressive therapy. The relation between clinical response and immunologic competence. New Engl. J. Med.277 163–170 (1967)
Tausch, G., Siegmeth, W.: Weitere Ergebnisse der Langzeittherapie mit Azathioprine bei erosiven Fällen von chronischer Polyarthritis. Z. Rheumaforsch.32 344–354 (1973)
Urowitz, M.B., Gordon, D.A., Smythe, H.A., Pruzanski, W., Ogryzlo, M.A.: Azathioprine in rheumatoid arthritis. Arthr. and Rheum.16 411–418 (1973)
Urowitz, M.B., Hunter, T., Bookman, A.A.M., Gordon, D.A., Smythe, H.A., Ogryzlo, M.A.: Azathioprine in rheumatoid arthritis. A double blind study comparing full dose to half dose. J. Rheum.1 274–281 (1974)
Wirth, W., Müller, U.St., Thöne, F.: Untersuchungen zum Wirkungsmechanismus sogenannter Immunsuppressiva. Arzneimittelallergie (Suppl.)1 282–287 (1974)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Goebel, K.M., Janzen, R., Joseph, K. et al. Disparity between clinical and immune responses in a controlled trial of azathioprine in rheumatoid arthritis. Eur J Clin Pharmacol 9, 405–410 (1976). https://doi.org/10.1007/BF00606556
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00606556